Company Filing History:
5 out of 152 
2 out of 1,454 
1 out of 1 
Years Active: 1993-2007
Title: Bernard Ferrari: Innovator in Pharmaceutical Chemistry
Introduction
Bernard Ferrari is a notable inventor based in Les Matelles, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work primarily focuses on the development of compounds that have therapeutic applications, particularly in treating inflammatory diseases.
Latest Patents
One of his latest patents is titled "Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same." This invention relates to compounds that exhibit affinity for bradykinin receptors, specifically with selectivity towards the B receptors. These compounds are promising for the preparation of medicinal products aimed at treating or preventing inflammation pathologies and chronic inflammatory diseases. Another significant patent involves N-(arylsulphonyl) amino acid derivatives, which further showcases his innovative approach in this domain.
Career Highlights
Throughout his career, Bernard Ferrari has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Synthelabo. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
Bernard has collaborated with notable professionals in his field, including Pierre Perreaut and Jean Gougat. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Bernard Ferrari's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of treatments for inflammatory diseases, showcasing the importance of innovation in healthcare.